0. DOCID:17933 SCORE: 0.00544580033304978
DOCNO: 1372399
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: complications
QUALIFIER: complications
QUALIFIER: etiology
QUALIFIER: etiology
AUTHOR: J B Epstein JB
AUTHOR: S Silverman S
AFFILIATION: Division of Dentistry, British Columbia Cancer Agency, Vancouver, Canada.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Oral surgery, oral medicine, and oral pathology.
COUNTRY: UNITED STATES
TITLE: Head and neck malignancies associated with HIV infection.
PUBDATE: 19920201
Immunosuppressed persons are at greater risk of developing malignancies. In human immunodeficiency virus (HIV) immunosuppression the most common oral cancers are Kaposi's sarcoma and non-Hodgkin's lymphoma. Squamous cell carcinoma has also been reported to be associated with HIV disease. Kaposi's sarcoma is the most frequent neoplastic disease in acquired immunodeficiency syndrome and is by far the most common in the head and neck area. This article reviews the prevalence, clinical features, and management of these diseases in HIV infection.

1. DOCID:19757 SCORE: 0.00482007106694167
DOCNO: 8371372
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Bladder
QUALIFIER: surgery
QUALIFIER: surgery
QUALIFIER: surgery
QUALIFIER: surgery
AUTHOR: R J Hedden RJ
AUTHOR: N Husseinzadeh N
AUTHOR: R B Bracken RB
AFFILIATION: Department of Surgery, University of Cincinnati Medical Center, Ohio.
PUBTYPE: Journal Article
JOURNALTITLE: The Journal of urology.
COUNTRY: UNITED STATES
TITLE: Bladder sparing surgery for locally advanced female urethral cancer.
PUBDATE: 19931001
Cystectomy remains one of the standard treatments for women with locally advanced (stage C) urethral cancer, or stage A or B lesions that have failed radiation therapy. Often, the urethral neoplasm does not invade the bladder. We treated 5 women with stage C urethral cancer by wide local excision with or without concomitant radiation therapy, while preserving the bladder. Local control was achieved in all patients with followup ranging from 4 to 75 months (median 42). We believe that bladder sparing treatment strategies should be considered for selected stage C tumors when the bladder is not invaded by the neoplasm.

2. DOCID:19482 SCORE: 0.00438316270256066
DOCNO: 1526520
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Uterine Cervical Neoplasms
QUALIFIER: secondary
QUALIFIER: secondary
QUALIFIER: secondary
AUTHOR: L Kumar L
AUTHOR: R K Tanwar RK
AUTHOR: S P Singh SP
AFFILIATION: Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, Ansari Nagar, New Delhi.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Gynecologic oncology.
COUNTRY: UNITED STATES
TITLE: Intracranial metastases from carcinoma cervix and review of literature.
PUBDATE: 19920901
Brain metastases from primary cervical carcinoma are uncommon. Only 41 cases have been reported so far in the English literature. We have seen 2 cases over the last 2 years among 481 patients with cervical cancer. Brain metastases developed 7 and 35 months after the primary diagnosis. One patient with solitary metastasis had no evidence of disease elsewhere and is free of disease after surgery and radiation therapy 7 months after the brain metastasis. Another patient with multiple brain metastases and cervical disease is alive 2 months after palliative radiation therapy.

3. DOCID:17885 SCORE: 0.00418667233431429
DOCNO: 1877115
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: administration & dosage
QUALIFIER: surgery
AUTHOR: H W Herr HW
AFFILIATION: Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.
PUBTYPE: Journal Article
JOURNALTITLE: The Urologic clinics of North America.
COUNTRY: UNITED STATES
TITLE: Transurethral resection and intravesical therapy of superficial bladder tumors.
PUBDATE: 19910801
The treatment of superficial bladder cancer is aimed at eradicating existing disease, inhibiting tumor recurrence, and preventing progression to invasion or metastasis. Transurethral resection is the primary modality, with intravesical therapy used in some cases to kill residual overt or occult carcinoma and premalignant lesions. Among the agents tested extensively, BCG appears to be more effective than mitomycin C, doxorubicin, or thiotepa, especially against carcinoma in situ. A number of questions remain to be answered about the management of this disease.

4. DOCID:19909 SCORE: 0.00396748367295342
DOCNO: 2040753
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Models, Biological
DESCRIPTOR: Mohs Surgery
DESCRIPTOR: Teaching Materials
QUALIFIER: surgery
QUALIFIER: surgery
AUTHOR: D J Leffell DJ
AFFILIATION: Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06510.
PUBTYPE: Journal Article
JOURNALTITLE: The Journal of dermatologic surgery and oncology.
COUNTRY: UNITED STATES
TITLE: An educational device for Mohs micrographic surgery. A three-dimensional model of basal cell carcinoma.
PUBDATE: 19910601
Mohs micrographic surgery for skin cancer (fresh-tissue technique) involves the processing of tissue in a complex fashion. The advantages of this method relate to the asymmetric three-dimensional growth of basal cell carcinoma (BCC). A device is described here based on published knowledge about the growth of BCC. The model demonstrates the precise way in which Mohs surgery varies from other surgical approaches to yield higher cure rates in specific circumstances. This device may be helpful in educating residents and medical students about Mohs surgery and in preparing patients for this procedure.

5. DOCID:16860 SCORE: 0.0039081662091143
DOCNO: 1692981
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnosis
QUALIFIER: blood
QUALIFIER: diagnosis
QUALIFIER: blood
AUTHOR: G P Manca GP
AFFILIATION: Divisione di Urologia, U.S.S.L. n. 22, Ospedale Civile, Sondrio.
PUBTYPE: Journal Article
JOURNALTITLE: Minerva medica.
COUNTRY: ITALY
TITLE: [The role of PSA in prostatic adenocarcinoma]
PUBDATE: 19900401
The introduction of new tumours markers poses the problem of assessing their real predictive power and of considering all their possible uses. The following questions have been examined: 1) is PSA able to offer early diagnosis of prostate Ca 2) is there a relationship between cancer grading and PSA levels? 3) is it possible to use PSA to monitor patients under treatment? 4) can PSA predict the existence of bone metastasis?

6. DOCID:18280 SCORE: 0.00348908056530081
DOCNO: 2249312
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: chemistry
QUALIFIER: chemistry
QUALIFIER: analysis
AUTHOR: M Liu M
AFFILIATION: China-Japan Friendship Hospital, Beijing.
PUBTYPE: Journal Article
JOURNALTITLE: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.
COUNTRY: CHINA
TITLE: [Transforming growth factor-alpha in human lung cancer tissue]
PUBDATE: 19900601
12 cases of human lung cancer tissue were analyzed for the presence of transforming growth factor-alpha with RIA. Histologically 9 were squamous cell carcinoma and 3 were adenocarcinoma. Except one squamous carcinoma, TGF-alpha could be detected in 11 cases. TGF-alpha level was from 0.26 ng to 1.26 ng per gram tissue. There was no significant difference in TGF-alpha level between squamous cell carcinoma and adenocarcinoma. The relationship between TGF-alpha and human lung cancer remains for further study.

7. DOCID:19893 SCORE: 0.00323646862090166
DOCNO: 1551076
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: ultrastructure
QUALIFIER: genetics
QUALIFIER: pathology
AUTHOR: C Sreekantaiah C
AUTHOR: M K Bhargava MK
AFFILIATION: Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India.
PUBTYPE: Journal Article
JOURNALTITLE: Cancer genetics and cytogenetics.
COUNTRY: UNITED STATES
TITLE: Double minute chromatin bodies in carcinoma of the human cervix uteri.
PUBDATE: 19920201
In direct G-banded preparations of 150 cases of cervical cancer, double minutes (dmin) were observed in 43% (64 cancers) of the patients, including a case of carcinoma-in-situ (CIS). The incidence of dmin varied from 1 to over 20 per cell. The karyotypic findings in the tumors containing dmin did not reveal any similarities and the prognosis of the patients with dmin was significantly worse compared to those without dmin. The presence of dmin in cytogenetic preparations of primary tumors may indicate a role in the maintenance and/or progression of malignancy, particularly as dmin have been suggested to represent amplified genes.

8. DOCID:16761 SCORE: 0.00311022438461839
DOCNO: 1497830
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Nursing Diagnosis
QUALIFIER: nursing
QUALIFIER: therapy
AUTHOR: T J Aitken TJ
PUBTYPE: Journal Article
JOURNALTITLE: Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.
COUNTRY: UNITED STATES
TITLE: Gastrointestinal manifestations in the child with cancer.
PUBDATE: 19920701
Pediatric oncology nurses provide a major role in the assessment and management of gastrointestinal complications in children resulting from cancer therapies. The clinical problems most frequently seen in this area include stomatitis, nausea, vomiting, constipation, and diarrhea. These areas are reviewed in detail according to various nursing diagnoses including definitions and pathophysiology, recent studies and interventions, special considerations for children, and patient and parent education.

9. DOCID:16152 SCORE: 0.00306824603613326
DOCNO: 1488833
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: pathology
QUALIFIER: secondary
QUALIFIER: pathology
AUTHOR: Z Kula Z
AFFILIATION: Kliniki Chorób Wewnetrznych Wojskowego Szpitala Klinicznego, Bydgoszczy.
PUBTYPE: Case Reports
PUBTYPE: Journal Article
JOURNALTITLE: Wiadomości lekarskie (Warsaw, Poland : 1960)
COUNTRY: POLAND
TITLE: [Neoplastic cavities of the lungs in cancer of the pancreas]
PUBDATE: 19920801
A 51-year-old females patient is reported in whom during pancreatic cancer massive oligosymptomatic and rapidly progressing breakdown of the pulmonary tissue of both apices of the lungs appeared. The cause was the presence of very numerous minute metastases of pancreatic cancer.

10. DOCID:19855 SCORE: 0.00264680250552111
DOCNO: 8258007
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: therapeutic use
QUALIFIER: therapy
AUTHOR: R Costello R
AUTHOR: C Lipcey C
AUTHOR: D Olive D
AFFILIATION: Unité INSERM U119 Cancérologie et Thérapeutique Expérimental, Marseille, France.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: The European journal of medicine.
COUNTRY: FRANCE
TITLE: Rationale for the utilization of interleukin-4, an immune-recognition induced cytokine, in cancer immunotherapy.
PUBDATE: 19930101
Interleukin-2 use for advanced cancer treatment has demonstrated that cytokines are of interest not only in the field of immunology but also in oncology. Interleukin-2 is only one member of the ever-growing family of immune recognition-induced lymphokines. Interleukin-4, a cytokine with pleiotropic effects, shares some common properties with interleukin-2. Availability of recombinant interleukin-4 has led to a better knowledge of this cytokine's functions, and also makes clinical trials possible. This brief review discusses the in vitro and in vivo data that support a potential use of interleukin-4 in cancer immunotherapy.

11. DOCID:17163 SCORE: 0.00252320244987745
DOCNO: 1306413
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: pathology
QUALIFIER: metabolism
QUALIFIER: metabolism
AUTHOR: X L Zhang XL
AFFILIATION: Department of Respiratory Medicine China-Japan Friendship Hospital.
PUBTYPE: Journal Article
JOURNALTITLE: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.
COUNTRY: CHINA
TITLE: [The study of alveolar macrophage nitroblue tetrazolium reduction in patients with lung cancer]
PUBDATE: 19921001
Authors studied experimentally PAM NBT reduction function in patients with lung cancer. Results indicate that PMN and lymphocyte counts in the lung cancer group are significantly lower than that in the control group, and NBT reduction of PAM is significantly decreased. We conclude that host defense and immune function in patients with lung cancer are decreased.

12. DOCID:17520 SCORE: 0.0025208871178891
DOCNO: 8506172
OWNER: NLM
STATUS: MEDLINE
DESCRIPTOR: Thromboembolism
QUALIFIER: complications
AUTHOR: M S Dhami MS
AUTHOR: R D Bona RD
AFFILIATION: University of Connecticut School of Medicine, Farmington.
PUBTYPE: Journal Article
PUBTYPE: Review
JOURNALTITLE: Postgraduate medicine.
COUNTRY: UNITED STATES
TITLE: Thrombosis in patients with cancer.
PUBDATE: 19930601
The relationship between cancer and abnormalities of blood coagulation has been recognized for well over a century. Deep venous thrombosis of the lower extremities is most common, but pulmonary embolism, upper extremity vein thrombosis, disseminated intravascular coagulation, and other, more unusual, clinical events may occur. Chemotherapy also has been linked to thrombotic episodes. Anticoagulant therapy is appropriate in many patients with venous or arterial thrombosis. Prophylaxis of venous thrombosis is particularly important in hospitalized cancer patients who are at bed rest or undergoing surgery.

13. DOCID:19369 SCORE: 0.00250601534431766
DOCNO: 8319269
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: surgery
AUTHOR: A Dörr A
AUTHOR: L Pilka L
AUTHOR: J Jelínek J
AUTHOR: Z Hortíková Z
AFFILIATION: II. gynek.-porod, klinika LF MU, Brno.
PUBTYPE: Journal Article
JOURNALTITLE: Ceskoslovenská gynekologie.
COUNTRY: CZECHOSLOVAKIA
TITLE: [The role of the second-look operation in modern therapy of ovarian carcinoma]
PUBDATE: 19930201
The authors evaluate the results of second look operations of ovarian cancer in a group of 34 women. The second look operation was preceded by intraperitoneal and intravenous chemotherapy. This therapeutic protocol contributed to improvement of therapeutic results. In 50% of thus treated women it proved possible to remove the residual tumour and the survival time was prolonged in 75% of women by 1-3 years. The advantages of this therapeutic procedure are according to the authors in particular reduction of the risk of super-radical primary operations and facilitation of the decision whether to terminate treatment or proceed with it.

14. DOCID:19275 SCORE: 0.00247112327268497
DOCNO: 1660741
OWNER: NLM
STATUS: MEDLINE
QUALIFIER: diagnostic use
QUALIFIER: immunology
QUALIFIER: immunology
AUTHOR: M A Goncharskaia MA
AUTHOR: I M Rutkevich IM
AUTHOR: A G Tonevitskiĭ AG
AUTHOR: N F Orel NF
AUTHOR: A V Vasil'ev AV
AUTHOR: N I Perevodchikova NI
AUTHOR: E B Mechetner EB
PUBTYPE: Journal Article
JOURNALTITLE: Biulleten' eksperimental'noĭ biologii i meditsiny.
COUNTRY: USSR
TITLE: [Monoclonal antibodies to human small-cell lung cancer]
PUBDATE: 19910901
Murine monoclonal antibodies to human small cell lung cancer (SCLC) have been developed and partially characterized. Primary hybridoma clones were screened in the indirect immunofluorescence assay (IFA) on alive H417 cells. Then five clones (IgG1, IgG2a, IgG3 and IgM) non-reactive with normal human bone marrow cells and positively reactive with SCLC tumors were selected. The H417.3 antibody is directed against 47-50kD surface antigens of H417 cells. The antibodies are supposed to be applied for the immunodetection of SCLC metastases to bone marrow and immunotoxin preparations.